These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12365204)

  • 61. The efficiency of different search strategies in estimating parsimony jackknife, bootstrap, and Bremer support.
    Müller KF
    BMC Evol Biol; 2005 Oct; 5():58. PubMed ID: 16255783
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
    Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
    Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Population pharmacokinetics of ertapenem in juvenile and old rats.
    Boulamery A; Marsot A; Bruguerolle B; Simon N
    Fundam Clin Pharmacol; 2014 Apr; 28(2):144-50. PubMed ID: 23647486
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of pharmacokinetic parameters of vancomycin via bootstrap methods.
    Zellner D; Frankewitsch T; Keller F
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):554-60. PubMed ID: 9799061
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Application of non parametric methods to pharmacokinetic models of the Michaelis-Menten type.
    Pereira LM; Maya MT; Morais JA
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():497-500. PubMed ID: 1820929
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of some practical sampling strategies for population pharmacokinetic studies.
    Jonsson EN; Wade JR; Karlsson MO
    J Pharmacokinet Biopharm; 1996 Apr; 24(2):245-63. PubMed ID: 8875349
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of hypothesis testing for comparing two populations using NONMEM analysis.
    White DB; Walawander CA; Liu DY; Grasela TH
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):295-313. PubMed ID: 1522482
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Simulation studies of errors of parameter estimates in pharmacokinetics.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):7-14. PubMed ID: 3838673
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr.
    Le Louedec F; Puisset F; Thomas F; Chatelut É; White-Koning M
    CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1208-1220. PubMed ID: 34342170
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three new residual error models for population PK/PD analyses.
    Karlsson MO; Beal SL; Sheiner LB
    J Pharmacokinet Biopharm; 1995 Dec; 23(6):651-72. PubMed ID: 8733951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design.
    Bonate PL
    Pharm Res; 1998 Mar; 15(3):405-10. PubMed ID: 9563069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of the standard approach and the NONMEM approach in the estimation of bioavailability in man.
    Combrink M; McFadyen ML; Miller R
    J Pharm Pharmacol; 1997 Jul; 49(7):731-3. PubMed ID: 9255720
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Automated covariate model building within NONMEM.
    Jonsson EN; Karlsson MO
    Pharm Res; 1998 Sep; 15(9):1463-8. PubMed ID: 9755901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM.
    Bressolle F; Gomeni R
    J Pharmacokinet Biopharm; 1998 Jun; 26(3):349-61. PubMed ID: 10098104
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.
    Savic RM; Mentré F; Lavielle M
    AAPS J; 2011 Mar; 13(1):44-53. PubMed ID: 21063925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of dose selection on parameter estimation using a rapid binding approximation model of target-mediated drug disposition.
    Marathe A; Van Wart S; Mager DE
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):223-35. PubMed ID: 21165681
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Estimation of pharmacokinetic parameters by orthogonal regression: comparison of four algorithms.
    Tod M; Aouimer A; Petitjean O
    Comput Methods Programs Biomed; 2002 Jan; 67(1):13-26. PubMed ID: 11750944
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):635-51. PubMed ID: 7334463
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The use of population pharmacokinetics in drug development.
    Vozeh S; Steimer JL; Rowland M; Morselli P; Mentre F; Balant LP; Aarons L
    Clin Pharmacokinet; 1996 Feb; 30(2):81-93. PubMed ID: 8906893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.